scholarly journals Effectiveness and cost-effectiveness of imatinib for first-line treatment of chronic myeloid leukaemia in chronic phase: a systematic review and economic analysis

2004 ◽  
Vol 8 (28) ◽  
Author(s):  
K Dalziel ◽  
A Round ◽  
K Stein ◽  
R Garside ◽  
A Price
Keyword(s):  
Systematic Review ◽  
Cost Effectiveness ◽  
Chronic Myeloid Leukaemia ◽  
Economic Analysis ◽  
Myeloid Leukaemia ◽  
Chronic Phase ◽  
Line Treatment ◽  
First Line ◽  
First Line Treatment

scholarly journals Clinical Profile and Response to First Line Treatment in Chronic Phase of Chronic Myeloid Leukaemia

2020 ◽  
Vol 9 (52) ◽  
pp. 3973-3976
Author(s):  
Sivasubramaniam K. ◽  
Latha K. V.S. ◽  
Abhishek R. ◽  
Niranjan V. ◽  
Tintu M.V ◽  
...  
Keyword(s):  
Chronic Myeloid Leukaemia ◽  
Myeloid Leukaemia ◽  
Chronic Phase ◽  
Clinical Profile ◽  
Line Treatment ◽  
First Line ◽  
First Line Treatment

scholarly journals Ponatinib as first-line treatment for patients with chronic myeloid leukaemia in chronic phase: a phase 2 study

2015 ◽  
Vol 2 (9) ◽  
pp. e376-e383 ◽  
Author(s):  
Preetesh Jain ◽  
Hagop Kantarjian ◽  
Elias Jabbour ◽  
Graciela Nogueras Gonzalez ◽  
Gautam Borthakur ◽  
...  
Keyword(s):  
Chronic Myeloid Leukaemia ◽  
Myeloid Leukaemia ◽  
Chronic Phase ◽  
Line Treatment ◽  
Phase 2 ◽  
First Line ◽  
Phase 2 Study ◽  
First Line Treatment

First line treatment of chronic phase chronic myeloid leukaemia patients with the generic formulations of imatinib mesylate

2014 ◽  
Vol 167 (1) ◽  
pp. 139-141 ◽  
Author(s):  
Ahmet Emre Eskazan ◽  
Mesut Ayer ◽  
Bulent Kantarcioglu ◽  
Deniz Arica ◽  
Naciye Demirel ◽  
...  
Keyword(s):  
Chronic Myeloid Leukaemia ◽  
Myeloid Leukaemia ◽  
Imatinib Mesylate ◽  
Chronic Phase ◽  
Line Treatment ◽  
First Line ◽  
First Line Treatment
Sign in / Sign up

Export Citation Format

Share Document